Biotechnology | Infectious Disease | Measles | Vaccine | WHO
WHO Reports Measles deaths down 88% since 2000, but cases surge
On Nov. 28, 2025, the the World Health Organization (WHO) reported that global immunization efforts have led to…
-
-
FDA Withdraws Testing Methods for Detecting and Identifying Asbestos in Talc-Containing Cosmetic Products
On Nov. 28, 2025, The Food and Drug Administration (FDA) announced the withdrawal of the proposed rule entitled…
-
China bans pork imports from Barcelona after Spain’s swine fever outbreak
On Nov. 28, 2025, China has banned pork imports from Barcelona province after Spain detected its first case…
-
Old air samples hint at effects of climate change
On Nov. 26, 2025, researchers at Lund University in Sweden have showed through the DNA analysis of old…
-
Artificial Intelligence | Biology | Diagnostics | Disease | Medicine | Pharmaceutical | Therapeutics
MIT scientists debut a generative AI model that could create molecules addressing hard-to-treat diseases
On Nov. 25, 2025, a team of Massachusetts Institute of Technology scientists reported that AI model BoltzGen generates…
-
Artificial Intelligence | Biotechnology | Medical Device | Medicine | Nanotechnology | Neurology | Non-Profit Research | Pharmaceutical | Therapeutics
University at Buffalo to receive $50 million for biofabrication and imaging research hub
On Nov. 25, 2025, Governor Kathy Hochul announced the University at Buffalo (UB) will receive $50 million from…
-
Disease | Environmental | USDA
Pathogens spread by high-flying wind-borne mosquitoes
On Nov. 25, 2025, recent studies published in PNAS have revealed that many mosquito species regularly engage in…
-
Combination of immunotherapy and targeted therapy improves survival for patients with advanced colorectal cancer
On Nov. 24, 2025, a new study led by UCLA investigators found that combining zanzalintinib, a targeted therapy…
-
Doctors still outperform AI in clinical reasoning, study shows
On Nov. 24, 2025, a study published in the New England Journal of Medicine show that a test…
-
New AI model could speed rare disease diagnosis
On Nov. 24, 2025, a new AI model called popEVE developed by Harvard Medical School researchers and colleagues…
-
CDC | Clinical Research | HIV | Infectious Disease | Medicine | NIH | Non-Profit Research | Therapeutics | U.S. Congress | Veterinary
U.S. Centers for Disease Control and Prevention to End Monkey Research Program
On Nov. 21, 2025, the U.S. Centers for Disease Control and Prevention (CDC) announced it has instructed staffers…
-
U.S. FDA Approves PADCEV® plus Keytruda® for Certain Patients with Bladder Cancer
On Nov. 21, 2025, Pfizer and Astellas Pharma announced that the U.S. Food and Drug Administration (FDA) has…
-
WHO Reports Diphtheria outbreak in African Region
On Nov. 21, 2025, the World Health Organization (WHO) reported that from 1 January to 2 November 2025,…
-
Biotechnology | CDC | Genomics | Infectious Disease | Influenza | Measles | Neurology | Vaccine
The West Coast Health Alliance Stands with Scientific Evidence: Vaccines Are Not Linked to Autism
On Nov. 21, 2025, state health officials from California, Oregon, Hawaii and Washington issued a statement in response…
-
Biotechnology | COVID-19 | Diagnostics | Infectious Disease | Influenza | Medical Device | Nanotechnology
new antibody test only takes 10 minutes, no blood draw necessary
On Nov. 20, 2025, an interdisciplinary research team at the University of Pittsburgh has developed wearable biosensors that…
-
Agriculture | Artificial Intelligence | Biotechnology | CRISPR | Diagnostics | Environmental | Forestry | Genomics | Infectious Disease | Marine Science | Materials | Nanotechnology | NIH | Non-Profit Research | Oncology | Pharmaceutical | Quantum | Rare Disease | Robotics | Software | Stem Cell | Therapeutics | U.S. Congress | Vaccine | Women's Health
Report Shows How University Research Spending Benefits U.S. Businesses
On Nov. 20, 2025, the Institute for Research on Innovation and Science (IRIS) released a report that demonstrates…
-
Biotechnology | FDA | Oncology | Therapeutics
FDA approves first cancer drug based on Broad Institute science
On Nov. 20, 2025, the US Food and Drug Administration (FDA) has approved the first cancer drug based…
-
Biotechnology | Cardiology | Clinical Research | CRISPR | Disease | FDA | Genomics | HIV | Infectious Disease | Influenza | Nanotechnology | Neurology | NIH | Oncology | Organ Transplant | Rare Disease | Stem Cell | Therapeutics | U.S. Congress | Vaccine | Women's Health
Halted NIH Clinical Trials List Reveals Slashed Treatments for Cancer, COVID and Minority Health
On Nov. 20, 2025, the National Institutes of Health (NIH) has canceled funding for at least 383 clinical…
-
CPRIT approves $154 million in new cancer research and prevention awards, surpasses $4 billion total
On Nov. 19, 2025, the governing board of the Cancer Prevention and Research Institute of Texas (CPRIT) approved…
-
Neurolgic Form of Equine Herpes Virus Confirmed Following Texas Event
On Nov. 19, 2025, the Texas Animal Health Commission (TAHC) received confirmation of equine herpes myeloencephalopathy (EHM), the…
-
Clogged ‘drains’ in the brain a likely early-warning sign of Alzheimer’s disease
On Nov. 19, 2025, a study by researchers from Nanyang Technological University (NTU) Singapore announced they had discovered…
-
Phage Blueprint Reveals New Clues for Combating Drug-Resistant Bacteria
On Nov. 19, 2025, researchers announced a Ōtākou Whakaihu Waka-led study has produced a detailed blueprint of a…
-
Precise Bio Achieves World’s First 3D-Bio-Printed Corneal Implant
On Nov. 19, 2025, Precise Bio announced the first patient has been successfully treated with PB-001, the Company’s…
-
Novartis announces plans to build flagship manufacturing hub in North Carolina
On Nov. 19, 2025, Novartis, a leading global innovative medicines company, announced plans to expand its operations in…
-
CSL injects $2.3b into US for valuable blood plasma
On Nov. 18, 2025, CSL, Australia’s largest biotech company announced plans to expand its US presence with a…
-
Arrowhead Pharma Announces FDA Approval of REDEMPLO® (plozasiran) to Reduce Triglycerides in Adults with Familial Chylomicronemia Syndrome (FCS)
On Nov. 18, 2025, Arrowhead Pharmaceuticals announced that the U.S. Food and Drug Administration (FDA) has approved REDEMPLO…
-
Type 1 diabetes cured in mice with gentle blood stem-cell and pancreatic islet transplant
On Nov. 18, 2025, Stanford Medicine researchers reported that a combination blood stem cell and pancreatic islet cell…
-
Utah, South Carolina confirm more measles as CDC call suggests U.S. elimination status in jeopardy
On Nov. 18, 2025, state officials in Utah report 84 measles cases in the state in a weekly…
-
Johnson & Johnson to acquire Halda Therapeutics for $3.05 billion, revolutionize treatment of cancer
On Nov. 17, 2025, Johnson & Johnson announced that it has entered into a definitive agreement to acquire…
-
Biotechnology | Disease | FDA | Therapeutics
Sandoz launches TYRUKO® (natalizumab-sztn) in US, as first and only multiple sclerosis biosimilar
On Nov. 17, 2025, Sandoz announced that TYRUKO® (natalizumab-sztn) is available to patients in the US. Developed by…
